{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:11:45Z","timestamp":1789704705470,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.nmd.2026.107422","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:26:39Z","timestamp":1788971199000},"page":"107422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Longitudinal riboflavin response in homozygous SLC52A2 p.Pro134Leu: a Turkish kindred with riboflavin transporter deficiency type 2"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2530-0109","authenticated-orcid":false,"given":"Ali Zeki","family":"Bedir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haluk","family":"Topalo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2026.107422_bib0001","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/jcm6050052","article-title":"Riboflavin responsive mitochondrial dysfunction in neurodegenerative diseases","volume":"6","author":"Udhayabanu","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.nmd.2026.107422_bib0002","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.3390\/ijms21113847","article-title":"Riboflavin deficiency \u2014 Implications for general human health and inborn errors of metabolism","volume":"21","author":"Mosegaard","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2026.107422_bib0003","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.3390\/ijms20184416","article-title":"Reconstitution in proteoliposomes of the recombinant human riboflavin transporter 2 (SLC52A2) overexpressed in E. coli","volume":"20","author":"Console","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2026.107422_bib0004","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3945\/jn.110.122911","article-title":"Identification and comparative functional characterization of a new human riboflavin transporter hRFT3 expressed in the brain","volume":"140","author":"Yao","year":"2010","journal-title":"J Nutr"},{"key":"10.1016\/j.nmd.2026.107422_bib0005","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ajhg.2010.02.006","article-title":"Brown\u2013Vialetto\u2013Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54","volume":"86","author":"Green","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2026.107422_bib0006","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10545-010-9242-z","article-title":"Brown\u2013Vialetto\u2013Van Laere and Fazio\u2013Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment","volume":"34","author":"Bosch","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.nmd.2026.107422_bib0007","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10545-016-9924-2","article-title":"Clinical presentation and outcome of riboflavin transporter deficiency: mini review after five years of experience","volume":"39","author":"Jaeger","year":"2016","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.nmd.2026.107422_bib0008","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.nmd.2021.06.009","article-title":"Three cases of adult-onset Brown\u2013Vialetto\u2013Van Laere syndrome: novel variants in SLC52A3 gene and MRI abnormalities","volume":"31","author":"Carey","year":"2021","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2026.107422_bib0009","doi-asserted-by":"crossref","first-page":"102.e1","DOI":"10.1016\/j.neurobiolaging.2020.09.021","article-title":"BVVL\/FL features caused by SLC52A3 mutations; WDFY4 and TNFSF13B may be novel causative genes","volume":"99","author":"Khani","year":"2021","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.nmd.2026.107422_bib0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/brain\/awt315","article-title":"Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2","volume":"137","author":"Foley","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2026.107422_bib0011","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/jns.12587","article-title":"Benefit of high-dose oral riboflavin therapy in riboflavin transporter deficiency","volume":"28","author":"Fennessy","year":"2023","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.nmd.2026.107422_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.108023","article-title":"Recent advances in riboflavin transporter RFVT and its genetic disease","volume":"233","author":"Jin","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.nmd.2026.107422_bib0013","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.clinph.2015.05.012","article-title":"Pathophysiology of motor dysfunction in a childhood motor neuron disease caused by mutations in the riboflavin transporter","volume":"127","author":"Menezes","year":"2016","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.nmd.2026.107422_bib0014","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/dmcn.16083","article-title":"Long-term outcomes in children with riboflavin transporter deficiency and surveillance recommendations","volume":"67","author":"Fennessy","year":"2025","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.nmd.2026.107422_bib0015","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/ejhg.2015.259","article-title":"Genes for spinocerebellar ataxia with blindness and deafness (SCABD\/SCAR3, MIM# 271250 and SCABD2)","volume":"24","author":"Guissart","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2026.107422_bib0016","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.nmd.2026.107422_bib0017","series-title":"World Report on Hearing","year":"2021"},{"key":"10.1016\/j.nmd.2026.107422_bib0018","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.ajhg.2022.10.013","article-title":"Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3\/BP4 criteria","volume":"109","author":"Pejaver","year":"2022","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2026.107422_bib0019","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/metabo15070491","article-title":"Riboflavin transporter deficiency type 2: expanding the phenotype of the Lebanese founder mutation p.Gly306Arg in the SLC52A2 gene","volume":"15","author":"Jreissati","year":"2025","journal-title":"Metabolites"},{"key":"10.1016\/j.nmd.2026.107422_bib0020","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.3390\/ijms21197402","article-title":"Antioxidant amelioration of riboflavin transporter deficiency in motoneurons derived from patient-specific induced pluripotent stem cells","volume":"21","author":"Marioli","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2026.107422_bib0021","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/dmcn.16106","article-title":"Riboflavin supplementation in children with riboflavin transporter deficiency type 2 does not stop disease progression based on long-term follow-up","volume":"67","author":"Bertini","year":"2025","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.nmd.2026.107422_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.braindev.2025.104355","article-title":"Brown\u2013Vialetto\u2013Van Laere syndrome patients with unusual phenotypes: functional analysis of SLC52A2 and SLC52A3 variants","volume":"47","author":"Gayathri","year":"2025","journal-title":"Brain Dev"},{"key":"10.1016\/j.nmd.2026.107422_bib0023","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cca.2016.09.022","article-title":"SLC52A2 [p.P141T] and SLC52A3 [p.N21S] causing Brown\u2013Vialetto\u2013Van Laere syndrome in an Indian patient: first genetically proven case with mutations in two riboflavin transporters","volume":"462","author":"Udhayabanu","year":"2016","journal-title":"Clin Chim Acta"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896626010904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896626010904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:53:41Z","timestamp":1789703621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896626010904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":23,"alternative-id":["S0960896626010904"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2026.107422","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal riboflavin response in homozygous SLC52A2 p.Pro134Leu: a Turkish kindred with riboflavin transporter deficiency type 2","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2026.107422","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107422"}}